These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31472880)

  • 1. The Evolution from Hypertension to Heart Failure.
    Sorrentino MJ
    Heart Fail Clin; 2019 Oct; 15(4):447-453. PubMed ID: 31472880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between long-term prescription of febuxostat and the progression of heart failure with preserved ejection fraction in patients with hypertension and asymptomatic hyperuricemia.
    Pan JA; Lin H; Wang CQ; Zhang JF; Gu J
    Heart Vessels; 2020 Oct; 35(10):1446-1453. PubMed ID: 32430700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and Heart Failure.
    Slivnick J; Lampert BC
    Heart Fail Clin; 2019 Oct; 15(4):531-541. PubMed ID: 31472888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of systolic and diastolic properties of hypertensive heart failure using speckle-tracking echocardiography with high volume rates.
    Minatoguchi S; Kawasaki M; Tanaka R; Yoshizane T; Ono K; Saeki M; Nagaya M; Sato H; Nishigaki K; Noda T; Zile MR; Minatoguchi S
    Heart Vessels; 2017 Oct; 32(10):1202-1213. PubMed ID: 28638961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction.
    Tam MC; Lee R; Cascino TM; Konerman MC; Hummel SL
    Curr Hypertens Rep; 2017 Feb; 19(2):12. PubMed ID: 28233237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: A retrospective observational cohort study.
    Gu J; Fan YQ; Bian L; Zhang HL; Xu ZJ; Zhang Y; Chen QZ; Yin ZF; Xie YS; Wang CQ
    Eur J Prev Cardiol; 2016 Sep; 23(13):1421-8. PubMed ID: 26915580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between long-term prescription of aldosterone antagonist and the progression of heart failure with preserved ejection fraction in hypertensive patients.
    Gu J; Fan YQ; Han ZH; Fan L; Bian L; Zhang HL; Xu ZJ; Yin ZF; Xie YS; Zhang JF; Wang CQ
    Int J Cardiol; 2016 Oct; 220():56-60. PubMed ID: 27372043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
    Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH
    Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction.
    Melenovsky V; Borlaug BA; Rosen B; Hay I; Ferruci L; Morell CH; Lakatta EG; Najjar SS; Kass DA
    J Am Coll Cardiol; 2007 Jan; 49(2):198-207. PubMed ID: 17222731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction.
    Zhang L; Liebelt JJ; Madan N; Shan J; Taub CC
    Am J Cardiol; 2017 Jun; 119(11):1815-1820. PubMed ID: 28450040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of reduced longitudinal left ventricular systolic function in hypertensive patients with normal ejection fraction.
    Szelényi Z; Fazakas Á; Szénási G; Tegze N; Fekete B; Molvarec A; Hadusfalvy-Sudár S; Jánosi O; Kiss M; Karádi I; Vereckei A
    J Hypertens; 2015 Sep; 33(9):1962-9; discussion 1969. PubMed ID: 26154942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of renin-angiotensin-aldosterone system gene polymorphisms with left ventricular hypertrophy in patients with heart failure with preserved ejection fraction: A case-control study.
    Bahramali E; Firouzabadi N; Rajabi M; Manafi A; Zarghami M; Mousavi SM; Jamshidi J
    Clin Exp Hypertens; 2017; 39(4):371-376. PubMed ID: 28513230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition from asymptomatic diastolic dysfunction to heart failure with preserved ejection fraction: roles of systolic function and ventricular distensibility.
    Aizawa Y; Sakata Y; Mano T; Takeda Y; Ohtani T; Tamaki S; Omori Y; Tsukamoto Y; Hirayama A; Komuro I; Yamamoto K
    Circ J; 2011; 75(3):596-602. PubMed ID: 21282875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial hypertrophy and its role in heart failure with preserved ejection fraction.
    Heinzel FR; Hohendanner F; Jin G; Sedej S; Edelmann F
    J Appl Physiol (1985); 2015 Nov; 119(10):1233-42. PubMed ID: 26183480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mechanism of heart failure with normal ejection fraction.
    Maciver DH; Townsend M
    Heart; 2008 Apr; 94(4):446-9. PubMed ID: 17483129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction.
    Schwarzl M; Hamdani N; Seiler S; Alogna A; Manninger M; Reilly S; Zirngast B; Kirsch A; Steendijk P; Verderber J; Zweiker D; Eller P; Höfler G; Schauer S; Eller K; Maechler H; Pieske BM; Linke WA; Casadei B; Post H
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1407-18. PubMed ID: 26342070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction.
    Klotz S; Hay I; Zhang G; Maurer M; Wang J; Burkhoff D
    Hypertension; 2006 May; 47(5):901-11. PubMed ID: 16585423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary microvascular dysfunction in hypertrophy and heart failure.
    Camici PG; Tschöpe C; Di Carli MF; Rimoldi O; Van Linthout S
    Cardiovasc Res; 2020 Mar; 116(4):806-816. PubMed ID: 31999329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heart failure with preserved left ventricular ejection fraction].
    Maeder MT; Rickli H
    Praxis (Bern 1994); 2013 Oct; 102(21):1299-307. PubMed ID: 24129298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.